All HER2+ BC cell lines tested demonstrated high susceptibility to THZ1, with cell viability effectively suppressed at low nanomolar concentrations (average IC50 = 60 nM), similar to the effects seen in TNBC (Fig. 1a). Here, ERBB2 is linked to breast cancer.